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Silver nanoparticles produced 
from Cedecea sp. exhibit 
antibiofilm activity and remarkable 
stability
Priyanka Singh1, Santosh Pandit2, Carsten Jers1, Abhayraj S. Joshi1, Jørgen Garnæs3 & 
Ivan Mijakovic1,2*
With multidrug-resistant bacterial pathogens on the rise, there is a strong research focus on 
alternative antibacterial treatments that could replace or complement classical antibiotics. Metallic 
nanoparticles, and in particular silver nanoparticles (AgNPs), have been shown to kill bacterial biofilms 
effectively, but their chemical synthesis often involves environmentally unfriendly by-products. 
Recent studies have shown that microbial and plant extracts can be used for the environmentally 
friendly synthesis of AgNPs. Herein we report a procedure for producing AgNPs using a putative 
Cedecea sp. strain isolated from soil. The isolated bacterial strain showed a remarkable potential 
for producing spherical, crystalline and stable AgNPs characterized by UV–visible spectroscopy, 
transmission electron microscopy, dynamic light scattering, and Fourier transform infrared 
spectroscopy. The concentration of produced nanoparticles was 1.31 µg/µl with a negative surface 
charge of − 15.3 mV and nanoparticles size ranging from 10–40 nm. The AgNPs was tested against 
four pathogenic microorganisms S. epidermidis, S. aureus, E. coli and P. aeruginosa. The nanoparticles 
exhibited strong minimum inhibitory concentration (MIC) values of 12.5 and 6.25 µg/µl and minimum 
bactericidal concentration (MBC) values of 12.5 and 12.5 µg/mL against E. coli and P. aeruginosa, 
respectively. One distinguishing feature of AgNPs produced by Cedecea sp. extracts is their 
extreme stability. Inductively coupled plasma mass spectrometry and thermogravimetric analysis 
demonstrated that the produced AgNPs are stable for periods exceeding one year. This means that 
their strong antibacterial effects, demonstrated against E. coli and P. aeruginosa biofilms, can be 
expected to persist during extended periods.
Microbial infections and microbes’ resistance to commonly used antibiotics are the leading causes of death world-
wide, and this has a tremendous impact on public health and the health  economy1. Most pathogenic bacterial 
species tend to aggregate, adhere, multiply and form a 3-dimensional (3D) complex network on biotic or abiotic 
surfaces. This complex 3D multilayered network is known as  biofilm2. Biofilms hold dormant bacteria, which 
can move to another surface to form a new biofilm after maturation. The extracellular components of biofilms: 
polysaccharides, nucleic acids, proteins and lipids, interact with each other and the embedded bacterial  cells3. 
These extracellular components perform many functions such as adhesion, protection, nutrient and metabolite 
resourcing, and they confer resistance to the unfavorable surrounding environment and antimicrobial  agents4. 
Biofilms are a particularly effective shield against antibiotics, slowing down their penetration, provoking their 
enzymatic degradation, and providing shielded bacterial cells with an opportunity to develop resistance via 
genetic  changes5. Biofilm components have been recognized as excellent targets for antimicrobial  therapy4,6 
since biofilms’ disruption would render bacterial cells more vulnerable to antibiotics and the immune system. 
To overcome the limitation of antibiotics-based treatment of biofilms, new antimicrobial therapies are being 
developed. These include developing small molecules, immunomodulators, anti-virulence agents, antibodies, 
vaccines and metallic  nanoparticles7,8.
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Noble metals have been known for their antimicrobial properties throughout human history. Since ancient 
times, silver salts, metallic silver, and silver compounds have been successfully employed for preventing microbial 
 growth9. Advances in nanotechnology made it possible to synthesize silver nanoparticles (AgNPs), which, due to 
their large surface area to volume ratio, exhibit remarkable antibacterial properties against a range of microbial 
 pathogens10. To date, many reports have been published that showed the action of AgNPs against planktonic 
bacterial cells as well as biofilms of multidrug-resistant  bacteria11,12.
AgNPs offer several advantages for antibiofilm applications, such as the high surface area to volume ratio, 
inert nature, tunable physical properties such as shape and size, biocompatibility, and demonstrated bacteriostatic 
or bactericidal properties at very low  concentrations13. The antimicrobial action comes directly from AgNPs, as 
well as from silver ions  (Ag+) formed from their dissolution. Both AgNPs and  Ag+ ions can interact with multiple 
components of planktonic bacterial cells and biofilm components. Through these interactions, they interfere 
with bacterial metabolism and hamper outer cellular  functions14. Overall antimicrobial effect of AgNPs comes 
from a combination of cell wall destruction, structural protein destabilization, membrane protein inactivation, 
enzyme inactivation, inhibition of electron transport chain (ETC), damage to nucleic acids and oxidative stress 
elicited via reactive oxygen species (ROS) generation (Fig. 1)15. Thus, AgNPs have become a promising choice 
for antimicrobial  therapy16.
AgNPs can be synthesized using various methods that can be categorized as ’top-down’ or ’bottom-up’ 
approaches. The bottom-up approach i.e. ’building nanoparticles from silver atoms in an aqueous solution’ is 
the most widely used method. Conventional AgNPs synthesis methods use hazardous chemicals and solvents 
and specialized equipment, which make them very costly and cumbersome. In addition, some of those methods 
generate toxic by-products14. However, the so-called "biosynthesis" approach for AgNPs formation offers an 
environmentally friendly and low-cost  alternative17,18. Recently, several reports have been published describ-
ing ecologically friendly production of AgNPs using extracts of bacterial and plant cells as nano-factories with 
high potential for scaling  up19,20. Various biomolecules of plant and bacterial origin in these nano-factories 
(proteins, enzymes, vitamins, polysaccharides etc.) are known to interact with the produced AgNPs, enhancing 
their biocompatibility and  stability21. In particular, sugars, polyphenols, acids, proteins, terpenoids and polysac-
charides present in biological nano-factories strongly contribute to bio-reduction of silver ions to atomic silver, 
and thereby their deposition into AgNPs. These biological compounds cover the AgNPs’ surface, which in turn 
enhances their stability and biocompatibility 22,23.
Following the "biosynthesis" approach for NP synthesis, in the present study we examined for the first time 
the capacity of bacteria from the Cedecea family to support the production of AgNPs with antibiofilm potential. 
We have demonstrated that a Cedecea sp. environmental isolate can serve as a source of AgNPs with excellent 
Figure 1.  Schematic representation of the proposed mode of action for produced silver nanoparticles (AgNPs) 
on bacteria cell apoptosis.
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antibacterial properties, comparable to other biogenic AgNPs reported in the literature. A distinguishing feature 
of AgNPs produced extracellularly by Cedecea sp. is their extreme physical stability, leading to undiminished 
antibacterial effects for periods exceeding one year. Moreover, the extracellular synthesis confers an important 
advantage over intracellular synthesis by bacteria since it requires no additional steps for NPs  purification24, 
such as ultra-sonication, water or solvent washing. This makes the AgNPs production process more feasible 
and economical.
Materials and methods
Materials. Silver nitrate  (AgNO3), tryptic soya agar (TSA), and tryptic soya broth (TSB) were purchased 
from Sigma-Aldrich Chemicals, St. Louis, USA.
Isolation and 16S rDNA gene sequencing. Soil sample was collected in sterile poly bags from Technical 
University of Denmark (DTU) field, Lyngby, Denmark. For isolation, a previously reported methodology was 
 followed25. Briefly, the individual colonies were isolated by using the serial dilution technique on TSA plates. The 
isolated colonies were further screened out by allowing the strains to grow on TSA plate with 1 mM  AgNO3 at 
37 °C for 24 h. Molecular identification of the isolated bacteria was performed using 16S rDNA amplification 
and  sequencing26. Genomic DNA was isolated using the DNeasy Blood and Tissue Kit (Qiagen) and used as a 
template for PCR with the universal primers 27 F (5′-AGA GTT TGATCMTGG CTC AG-3′) and 1492 R (3′-TAC 
GGY TAC CTT GTT ACG ACTT-5′)27. Eurofins Genomics (Ebensburg, Germany) sequenced the PCR product 
and the sequence was analyzed using the NCBI BLAST homepage against the reference sequence database.
Synthesis and purification of AgNPs. "Biosynthesis" synthesis of AgNPs was done as reported 
 previously25. Briefly, 100 ml of overnight bacteria culture was spun down 8000 rpm for 5 min to get cell-free 
supernatant. 2 mM of  AgNO3 was added to this cell-free supernatant and incubated further at 37 °C for 24–48 h. 
The salt mix supernatant (reaction mixture) was monitored continuously for nanoparticle synthesis, by visual 
inspection and by recording UV–Vis spectra. AgNPs were purified by centrifugation at 14,000 rpm for 10 min. 
After centrifugation, the supernatant was discarded and AgNPs were washed 3 times with sterile water and 
obtained in the precipitate form. This residue was suspended again into sterile water and used for all experi-
ments. Figure 2 showed the schematic illustration of nanoparticles formation from the supernatant of Cedecea 
sp.
Analytical characterization of AgNPs. The UV–Vis spectrum of produced AgNPs was obtained using 
6705 UV–Vis spectrophotometer, JENWAY, by scanning it in the range of 300–700 nm. The optimization studies 
for AgNPs production were also conducted using UV–Vis  spectroscopy28. To analyze the internal morphology, 
composition and crystallographic information of produced AgNPs, transmission electron microscopy (TEM) 
Figure 2.  Schematics showing the stepwise procedure for AgNPs production from isolated Cedecea sp.
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was carried out using the FEI Tecnai T20 G2 instrument, operated at an acceleration voltage of 200 kV. AgNPs 
sample for TEM was prepared by spotting the pure NPs solution onto carbon coated cupper grid, followed by 
complete air-drying prior to examination in the microscope. The nanoparticle size distribution and the surface 
charge was studied by Dynamic light scattering (DLS) (Zetasizer Nano ZS, Chuo-ku Kobe-shi, Japan), follow-
ing the previously reported  methodology28. Atomic force microscopy (AFM) (Park NX20 from www. parka fm. 
com) measurements were carried out in intermittent contact mode using standard probes of single crystal highly 
doped silicon with a radius of curvature of less than 30 nm (SuperSharpSilicon™ Non-Contact AFM probes from 
Nanosensors). The standard uncertainty u(d) of the measured diameters are u(d) < 0.05 d. The FTIR measure-
ments were carried out using Nicolet iS50 (Thermo Fisher Scientific, Waltham, MA, USA) by scanning the 
air-dried purified AgNPs and cell’s supernatant over the range of 4000–450  cm−1 at a resolution of 4  cm−1. The 
recorded spectra recorded were plotted as transmittance (%) versus wavenumber  (cm−1)15.
For size fractionation and quantification of nanoparticles sp-ICP-MS (NexION 350D; PerkinElmer Inc., 
Waltham, MA, USA) was used in similar conditions as reported  previously29. Nanoparticle stability was studied 
by keeping the NPs solution in ambient conditions, such as different pH, time, temperature, and bacteriological 
media such as TSB and Luria broth (LB) for indicated amounts of time. The UV–Vis spectra were measured 
before and after the incubation period. The NPs were characterized by sp-ICP-MS, and UV–Vis for analyzing 
stability and spectra were measured before and after the incubation period. The thermal stability of nanopar-
ticles was determined by thermogravimetric analysis (TGA), for which the nanoparticles in powder form was 
performed on a Discovery TGA (TA Instruments, New Castle, DE, USA). For analyzing TGA, the nanoparticles 
were placed in an alumina pan and heated from 20 to 700 °C at a ramping time of 10 °C/min."
Bacterial strains and culture media. The antimicrobial activity of AgNPs was evaluated against four 
pathogens, comprising both Gram-positive and Gram-negative bacteria: Escherichia coli UTI 89, Pseudomonas 
aeruginosa PAO1, Staphylococcus epidermidis ATCC 35,984, and Staphylococcus aureus CCUG 10,778. LB 
medium was used for E. coli and P. aeruginosa, and TSB was used for S. epidermidis and S. aureus.
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 
AgNPs. The bacteriostatic and bactericidal activity of AgNPs was evaluated by measuring MIC and MBC, 
respectively, using the following microdilution assay. The bacteria cultures were grown overnight and diluted 
to approximately 1–2 ×  105 colony forming units (CFU)/mL. Then, the AgNPs were added in concentrations 
ranging from 1.56 to 50 µg/mL, in twofold dilution series. Samples were incubated at 37 °C, for 24 h. After 24 h, 
bacterial growth was measured by recording  OD550 for all samples. The MIC was defined as the lowest concentra-
tion of AgNPs, which inhibited the bacterial growth, measured as  OD550.
The MBC value was defined as the lowest concentration of AgNPs that was required to kill the bacterial strain. 
For measuring MBC, 100 µL of the mixtures as mentioned above was streaked on agar plates and incubated at 
37 °C overnight. This was followed by CFU counting to estimate the survival of bacterial  cells25.
Biofilm inhibition assay. For biofilm inhibition assay, the overnight grew bacterial culture was diluted to 
the final concentration of 1–2 ×  106 CFU/mL. 200 µL of this suspension was added to a 96-well plate and incu-
bated for 5 h at 37 °C. After the incubation period, different concentrations of AgNPs were added in the suspen-
sion and incubated further for 19 h at 37 °C. After 24 h (in total), the static biofilm formed on the wall of 96 well 
plates, the medium was carefully removed and the biofilm was washed twice with sterile water. The biofilms were 
stained with 0.1% crystal violet for 20 min, washed with water and dried at room temperature for 1 h. Finally, 
absolute ethanol (200 µL) was added to the stained biofilms, and the samples were agitated vigorously for 15 min 
to extract the stain. The absorbance of extracted crystal violet was measured at 590  nm28.
Bacterial viability after AgNPs exposure. Three different methods analyzed the biofilm inhibition 
activity of AgNPs: (1) by checking the bacterial viability, (2) by observing the cells under the scanning electron 
microscope (SEM), and (3) by live/dead staining  assay25,28. The inoculum of 2–5 ×  106 CFU/mL was obtained by 
diluting overnight cultures of E. coli and P. aeruginosa and loading the samples on top of a 15 mm cover glass. 
The cover glass was further incubated at 37 °C for 24 h, which allowed for biofilm formation. After 24 h, old cul-
ture medium was replaced with fresh medium, containing sterile water (negative control) or 1 × MBC, 2 × MBC, 
4 × MBC, or 8 × MBC of AgNPs. Sample were incubated for further 24 h. Then the biofilms were homogenized 
for 20 s in 0.89% NaCl. The obtained bacterial samples were serially diluted and plated on LB agar plates. Next, 
the plates were incubated overnight at 37 °C, followed by CFU counting. For live/dead cells staining, samples 
were stained for 20 min with a mixture of 6.0 μM SYTO 9 and 30 μM KI from Live/Dead BacLight Viability kit 
L13152, (Invitrogen, Molecular Probes, Inc. Eugene, Oregon, USA). Fluorescence microscopy were collected 
using a Zeiss fluorescence microscope (Axio Imager.Z2m Carl Zeiss, Zena, Germany). Further, control and 
AgNPs-treated biofilms were examined by SEM (Supra 60 VP microscope, Carl Zeiss AG)28.
Statistical analysis. All experiments were done in three biological and two technical replicates and data are 
presented as the mean ± standard deviation (SD). The intergroup differences were estimated by one-way analysis 
of variance (ANOVA), followed by a post hoc multiple comparisons (Tukey test). Values were considered statisti-
cally significant at p < 0.05.15.
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Results
Molecular characterization of the isolated environmental strain. The environmental isolate has 
been selected based on prescreening of individual colonies on TSA plates supplemented with 1 mM  AgNO3, 
which means the strain was able to tolerate silver salt at the desired conc. to produce nanoparticles. The sequenc-
ing of 16S rDNA from our bacterial strain isolated from soil indicated 98.17% identity with Cedecea lapagei 
strain DSM 4587. The isolated strain sequence number is submitted to NCBI with GenBank: MT524486.1. Cede-
cea lapagei  is reported to be a Gram-negative, non-sporulating, motile, non/encapsulated, rod-shaped bacilli, 
which belongs to the Enterobacteriaceae family. Various species of this genus have been reported to be isolated 
from various clinical specimens including sputum, urine, cutaneous and oral ulcers  etc30–32. Pending further 
molecular characterization, we will refer to this strain as Cedecea sp.
Cell-free supernatant of Cedecea sp. is a suitable medium for the synthesis of AgNPs. Super-
natant derived from an overnight culture of Cedecea sp. was supplemented with 1 mM  AgNO3 and used as a 
reducing medium for the production of AgNPs. After the incubation period, the supernatant showed visible 
colour change from pale yellow to deep brown,  (Fig. 3a)33. To investigate the production of AgNPs quantita-
tively, UV–Vis spectrophotometer analysis was performed by scanning the reaction mixture in the range of 300–
700 nm (Fig. 3a). The synthesis was confirmed by first directly scanning the reaction mixture after incubation 
period and then with purified nanoparticles suspension as well. The change in color is attributed to the surface 
plasmon resonance (SPR) property of  AgNPs34. In addition, the maximum absorbance of the reaction mixture 
was absorbed in the range of 400 nm to 500 nm, which is specifically for the  AgNPs35. Next, we attempted to 
optimize AgNPs production with respect to the amount of silver salt added, reaction temperature and incuba-
tion time. As shown in (Fig. 3b–d), optimal salt concentration was 2 mM, the optimal temperature was 37 °C, 
and the optimal incubation period was 48 h. Any further increase of these key parameters above the optimized 
values led to the disruption of UV–Vis peaks, indicating nanoparticle destabilization.
Produced AgNPs are in size range of 10–40 nm, covered with biological material and highly 
stable. The morphology of produced AgNPs was studied by TEM, which showed that the nearly spherical 
shape is a dominant form, with some polydispersity of triangular and hexagonal shapes. The size of the AgNPs 
was determined to range from 10 to 40 nm (Fig. 4a). To analyze the phase of nanoparticles, selected area elec-
tron diffraction (SAED) analysis was carried out (Fig. 4b), which yielded results consistent with polycrystalline 
 behavior36. The detected SAED pattern exhibited clear visible spots corresponding to the main reflection lattice 
planes of (111), (200), (220), and (311)24,37. The AFM analysis also showed the size of the nanoparticles falls in 
the range of 40–50 nm (Fig. 4c). Next, the size and surface charge of the produced AgNPs was examined by 
Figure 3.  UV/Vis spectra (a) unpurified AgNPs in supernatant and purified AgNPs. Optimization studies 
based on UV/Vis spectral analysis (b) temperature, (c) time, and (d) silver salt concentration.
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DLS. The average hydrodynamic diameter was determined to be 115.9 nm, with a polydispersity index (PDI) 
of 0.39 (Fig. 4d). The zeta potential value (surface charge) of the aqueous AgNPs solution at room tempera-
ture was found to be − 15.7 mV (Fig. 4e), which suggested that the NPs can be expected to be stable at neutral 
 conditions38. To determine whether any functional groups or molecules from the bacterial supernatant attached 
to the surface of nanoparticles, FTIR measurements were conducted. These measurements revealed many func-
tional groups specific for the bacterial cells’ supernatant to be present on the nanoparticles’ surface (Fig. 5a, b) 
(Table 1). For example, the peak observed at 3278.11  cm−1 for supernatant and 3241.87  cm−1 for AgNPs sug-
gested they both share O–H and N–H  stretching39. The asymmetric and symmetric C–H stretch was marked at 
Figure 4.  (a) Transmission electron microscopy images of produced AgNPs—nanoparticles shape and (b) 
selected area (electron) diffraction  (SAED) with respective apertures. (c) AFM analysis of nanoparticles (d) 
Particles size distribution concerning the intensity of AgNPs and (e) zeta potential distribution showed the 
negative zeta potential value. The study was done in triplicates, and the results are an average of three analyses.
Figure 5.  Fourier transform-infrared spectroscopy spectra of (a) Cell’s supernatant and (b) AgNPs.
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2924.19  cm−1 for cell and 2915.24 and 2848.56  cm−1 for AgNPs. The (carbonyl (C=O), amide I (N–H) and C=C 
groups were also found in both samples, in the region between 1600–1500  cm−1. The peaks identified at 1454.69 
and 1391.93  cm−1 for the supernatant and 1444.29  cm−1 for AgNPs correspond to the C–H bending of  COO− or 
carboxylate groups. The overlapping of C–O, C–N, C–O–C and C–O–P stretching modes was also detected in 
both samples, at 1053.72 and 1007.59  cm−1 for the supernatant and AgNPs, respectively. Thus, the FTIR results 
indicate the presence of proteins, amino acids and other biomolecules originating from the supernatant on the 
surface of the produced  AgNPs39. These active groups play a very important role in reducing metal salts and 
AgNPs stabilization.
To assess the efficiency of production by Cedecea sp., the concentration of AgNPs was determined by sp-
ICP-MS (Fig. 6a–d). The measured total mass concentration was 1.31 µg/µl, with a negligible dissolved fraction 
(< 0.1 ppb). Next, we assessed short- and long-term nanoparticle stability. The measurements were carried out 
after 24 h, 48 h and one year. Our results indicated no significant difference in particle size, resulting in mean 
diameters from 49–55 nm, which indicated that the nanoparticles were stable up to one  year28. The number of 
particles was not influenced by storage time, that no AgNPs dissolution or merging occurred even after one 
year. To confirm the aqueous stability, UV–Vis observations were made after two weeks of storing NPs in aque-
ous solution at room temperature and after one year at 4℃. As a result, no significant shift was observed, thus 
confirming the extreme aqueous stability of NPs (Fig. 6d). In addition, the AgNPs stability was tested in bac-
teriological media such as TSB and LB (Fig. 6e). The results indicated that the NPs are somewhat less stable in 
growth  media25. For thermal stability, the TGA measurement was conducted. Figure 6f demonstrates the weight 
loss profiles with increasing temperature. Degradation of nanoparticles commenced above 400 °C, correlated to 
the loss of the organic phase materials adsorbed on the NPs  surface40. A further increase in temperature up to 
600 °C led to complete degradation of  nanoparticles41.
Table 1.  Fourier transform-infrared spectroscopy (FT-IR) spectra of bacterial cell’s supernatant and AgNPs.
Type of Bond Cells Wavenumber  (cm−1) AgNPs Wavenumber  (cm−1)
O–H and N–H group 3278.11 3241.87
C–H group 2924.19 2915.24, 2848.56
Alkyne group 2166.25, 2050.16, 1079.59 2113.44, 1999.70, 1922.51
C=C, amide I (N–H), C=O groups 1633.57, 1531.44 1621.15, 1514.19
C–H bending,  COO− groups 1454.69, 1391.93 1444.29
Overlapping of C–O, C–N, C–O–C and C–O–P stretching modes 1053.72 1007.59
C–C deformation 521.78 521.74
Figure 6.  Inductively coupled plasma-mass spectrometry measurement of AgNPs, which shows the size 
distribution histogram. (a) ICP-MS measurement of AgNPs after 24 h, (b) 48 h, (c) 72 h (d) and one year of NPs 
formation (the green color shows the frequency of size distribution, and the orange line is the mean value). UV/
Vis spectra for nanoparticles (e) time-dependent stability at a difference of two weeks and one-year (f) stability 
of AgNPs in bacteriological media. (g) Thermogravimetric analysis of NPsin the range of temperature 0–700 ℃.
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AgNPs produced in Cedecea sp. successfully inhibit bacterial biofilms. We first set out to deter-
mine the bacteriostatic and bactericidal activity of obtained AgNPs against planktonic bacteria employing meas-
uring MIC and MBC of nanoparticles against E. coli, P. aeruginosa, S. aureus and S. epidermidis (Table 2). E. coli 
and P. aeruginosa were observed to be sensitive to AgNPs, with MIC values of 12.5 and 6.25 μg/ml and MBC 
values of 12.5 and 12.5 μg/ml, respectively. S. aureus and S. epidermidis were less sensitive to AgNPs, with both 
MIC and MBC values in the 100 μg/ml range (Table 2).
Next, synthesized AgNPs were tested for inhibiting the formation of biofilm by the same bacterial species 
(Fig. 7). Concentration-dependent inhibition of biofilm formation was observed in all cases, stronger for E. 
coli, P. aeruginosa and weaker for S. aureus and S. epidermidis (Fig. 7). Inhibition of formation of E. coli and P. 
aeruginosa biofilms occurred at sub-MIC concentration (0.25 × MIC). Inhibition of biofilm formation can occur 
due to direct bactericidal effects or by inhibiting viable bacterial cells’ attachment to the surface. To separate 
these two effects, next, we evaluated the direct bactericidal potential of AgNPs, by using mature, pre-formed 
biofilms of the two more sensitive species: E. coli and P. aeruginosa (Fig. 8). CFU counts determined viability of 
biofilm cells following the AgNPs treatment counts determined viability of biofilm cells following the AgNPs 
treatment. A significant reduction in bacterial cell viability in both types of biofilm was observed with AgNPs 
Table 2.  Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 
AgNPs against E. coli, P. aeruginosa, S. epidermis and S. aureus.
Bacterial strain MIC (µg/ml) MBC (µg/ml)
E. coli 12.5 12.5
P. aeruginosa 6.25 12.5
S. epidermidis 100 100
S. aureus 100 100
Figure 7.  Effect of AgNPs on bacterial biofilm formation. (a) E. coli, (b) P. aeruginosa, (c) S. epidermidis, and 
(d) S. aureus. Data represent mean ± standard deviation error. *p < 0.05; **p < 0.005; ***p < 0.0001.
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concentrations above 25 μg/ml (Fig. 8). In order to confirm the viability data obtained by CFU counting, we used 
live/dead  staining42. This method enables one to visualize individual live cells (stained green) and individual 
dead cells (stained red) under a fluorescence microscope (Fig. 9). These results confirmed a dramatic onset of 
the killing of bacterial cells at AgNPs concentrations above 25 μg/ml for both E. coli and P. aeruginosa biofilms. 
Given the known mechanism of killing bacterial cells by AgNPs, which involves extensive cell wall destruction 
and membrane protein  inactivation15, bacterial cells’ death should be accompanied by drastic morphological 
changes. To observe those, we used SEM (Fig. 10). A significant degree of morphological alteration was observed 
in AgNPs-treated biofilms. These included bacterial cells with visible membrane pores, cell lysis and leakage of 
intracellular content, clearly visible in both E. coli and P. aeruginosa biofilms. , The severity of these effects was 
correlated to the concentration of applied AgNPs for both bacterial species.
Figure 8.  CFU count after treatment with AgNPs (a) E. coli and (b) P. aeruginosa. Data represent 
mean ± standard deviation error. *p < 0.05; **p < 0.005; ***p < 0.0001.
Figure 9.  Live/dead staining image of biofilms observed by using fluorescence microscopy, (a) E. coli and (b) P. 
aeruginosa. Live cells stained green and dead cells stained red.
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Discussion
Our results indicate that Cedecea sp. can be a good host for the sustainable production of AgNPs with antibacte-
rial potential. Optimizing the synthesis methodology, we concluded that maximum yields are obtained at 37 °C, 
after 48 h. of incubation and using 2 mM  AgNO3 (Fig. 3). Further increases in any of these key parameters com-
promised nanoparticle stability. Nanoparticles produced by Cedecea sp. displayed several distinct advantages. 
The size of produced NPs within 10–40 nm offers a significant advantage in antibacterial applications because 
it favours the entry into target bacterial cells. The small size makes these nanoparticles also suitable for other 
medical applications, such as anticancer agents. 43.
FTIR confirmed the presence of a capping layer on the synthesized AgNPs. Although a slight shift in some 
peaks was observed (could be attributed to interactions between the biological compounds and AgNPs) our 
FTIR results agree with the published  literature25,44 and corroborate the presence of a stable capping layer. The 
FTIR measurements confirmed that the capping layer’s functional groups originated from the bacterial cells 
(Fig. 5). These groups are exposed on the NPs surface, where they contribute to NPs stability and play a role in 
the interaction of NPs with the surfaces of targeted bacteria. An important feature of the produced AgNPs is 
their inhibitory effect against biofilm-forming bacterial pathogens. The antibacterial and anti-biofilm activity 
of synthesized AgNPs was tested against both Gram-positive and Gram-negative bacterial strains. Recently, 
Shania et al. showed the Sphingobium sp. MAH-11 mediated AgNPs MICs value for E. coli and S. aureus were 
6.25 and 50 μg/mL, and the MBCs values were 25 and 100 μg/mL for E. coli and S. aureus,  respectively45. Our 
AgNPs showed significant antimicrobial activity against the Gram-negative bacteria E. coli and P. aeruginosa 
at low concentrations. In contrast, the Gram-positive bacteria S. epidermidis and S. aureus were observed to be 
less  sensitive46. This major difference in antibacterial effects against these two bacteria could be attributed to 
differences in bacterial surfaces. Gram-positive bacteria have a thick coating (20–80 nm) composed of nega-
tively charged peptidoglycan, which might impede the penetration of AgNPs and attenuate the activity of silver 
ions, resulting in overall weaker antibacterial effects. In contrast, Gram-negative bacteria have a thinner cell 
envelope (8–12 nm) with negatively charged lipopolysaccharides, which are known to promote the adhesion of 
 nanoparticles47. This makes the Gram-negative bacterial cells more susceptible to the treatment. Another con-
tributing factor could be the overall electrical charge at the surface of bacterial cells. Surfaces of Gram-negative 
bacteria typically have a lower isoelectric point (> pH 2) compared to surfaces of Gram-positive bacterial (pH 
3–4)48. It is hence possible that Gram-positive bacteria have a better capacity of neutralizing the charged func-
tional groups in the AgNPs capping layer, and thus reducing their capacity of interaction with the target cells. 
Even though our AgNPs showed lower inhibition of bacterial growth for the Gram-positive bacteria, they still 
showed a strong inhibitory effect on biofilm formation, even at the sub-MIC concentrations. These results sug-
gest that lower concentrations of AgNPs do not directly damage the bacterial cells; however, the release of silver 
ions after dissolution of the nanoparticles might be able to inhibit biofilm formation by altering gene expression 
or inhibiting quorum sensing within the  biofilm49. It has been previously shown that the antibacterial activity of 
Figure 10.  Scanning electron microscopy images of bacteria cells treated with different concentrations of 
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AgNPs is strongly correlated with their size. Smaller nanoparticles typically exhibit higher antimicrobial efficacy, 
due to easier internalization by bacterial cells. In the current study, the AgNPs were found to be in the size range 
between 10–40 nm, which corresponds well with the observed activity in damaging cell membrane and cellular 
components, clearly visible under SEM (Fig. 10). Our study’s overall findings support a robust antibiofilm activity 
of our AgNPs against biofilms produced by E. coli and P. aeruginosa.
The most notable feature of AgNPs synthesized by Cedecea sp. is their stability. Owing to the capping layer 
formed by biological compounds from the bacterial supernatant, the AgNPs remained stable in water and in 
different growth media. For antimicrobial applications of these NPs, their stability is of the utmost importance. 
The SAED aperture results showed that our AgNPs are crystalline (Fig. 4b), their mean hydrodynamic diameter of 
115 nm is stable, and they have a highly negative zeta potential value (Fig. 4e), all of which suggest high stability. 
The stability of AgNPs for up to one year was demonstrated by two independent methods (Fig. 6): the ICP-MS 
analysis and UV/Vis spectra recording. This remarkable stability of produced AgNPs most probably comes from 
the capping layer around the NPs surface, which is formed by the biological components secreted by Cedecea 
sp. Recently, Ragaa et al. also reported extreme stability of AgNPs produced by the cyanobacterium Oscillatoria 
limnetica. Stability was confirmed for up to 9 months, and the authors claimed that the capping agents helped 
in the long-term stabilization of the  nanoparticles44. Our temperature stability analysis demonstrated the cap-
ping layer’s involvement in stabilizing the nanoparticles (Fig. 6f)28. The organic phase materials adsorbed on the 
surface of the nanoparticle protected them up to 400 °C, and their gradual thermal destruction resulted in the 
complete disintegration of NPs at 600 °C.
Conclusion
Our overall conclusion is that the growth supernatant of isolated Cedecea sp. offers a beneficial medium for syn-
thesizing AgNPs for antibiofilm applications, particularly against Gram-negative pathogens. Functional groups 
from biomolecules present in the cell’s supernatant form a stable capping layer on the produced NPs, contributing 
to their stability and promoting their interaction with target bacterial cells. With stability documented for up 
to one year, these AgNPs hold considerable potential for long-term use against biofilms of E. coli, P. aeruginosa 
and other Gram-negative pathogens.
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